Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity
Open Access
- 29 January 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 79 (5-6) , 737-743
- https://doi.org/10.1038/sj.bjc.6690118
Abstract
The present study examined the ability of human monocytes to produce reactive oxygen intermediates after a contact with tumour cells. Monocytes generated oxygen radicals, as measured by luminol-enhanced chemiluminescence and superoxide anion production, after stimulation with the tumour, but not with untransformed, cells. The use of specific oxygen radical scavengers and inhibitors, superoxide dismutase, catalase, dimethyl sulphoxide and deferoxamine as well as the myeloperoxidase inhibitor 4-aminobenzoic acid hydrazide, indicated that chemiluminescence was dependent on the production of superoxide anion and hydroxyl radical and the presence of myeloperoxidase. The tumour cell-induced chemiluminescent response of monocytes showed different kinetics from that seen after activation of monocytes with phorbol ester. These results indicate that human monocytes can be directly stimulated by tumour cells for reactive oxygen intermediate production. Spontaneous monocyte-mediated cytotoxicity towards cancer cells was inhibited by superoxide dismutase, catalase, deferoxamine and hydrazide, implicating the role of superoxide anion, hydrogen peroxide, hydroxyl radical and hypohalite. We wish to suggest that so-called ‘spontaneous’ tumoricidal capacity of freshly isolated human monocytes may in fact be an inducible event associated with generation of reactive oxygen intermediates and perhaps other toxic mediators, resulting from a contact of monocytes with tumour cells.Keywords
This publication has 39 references indexed in Scilit:
- Prevention of necrosis and activation of apoptosis in oxidatively injured human myeloid leukemia U937 cellsPublished by Wiley ,1999
- C 2 ‐ceramide and C 6 ‐ceramide inhibited priming for enhanced release of superoxide in monocytes, but had no effect on the killing of leukaemic cells by monocytesImmunology, 1997
- Myeloperoxidase-Based Chemiluminescence of Polymorphonuclear Leukocytes and MonocytesJournal of Bioluminescence and Chemiluminescence, 1996
- Glycoconjugate profile and cd44 expression in human melanoma cell lines with different metastatic capacityInternational Journal of Cancer, 1995
- Activation of cytolytic activity in peripheral bloodInternational Journal of Cancer, 1993
- Tumour-cell-induced production of tumour necrosis factor by monocytes of gastric cancer patients receiving BCG immunotherapyCancer Immunology, Immunotherapy, 1993
- Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self-protection.The Journal of Experimental Medicine, 1993
- The origin and function of tumor-associated macrophagesImmunology Today, 1992
- Dissociation of responses measured by natural cytotoxicity and chemiluminescenceEuropean Journal of Immunology, 1984
- Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity.The Journal of Experimental Medicine, 1979